Thursday, March 25, 2021
PharmGKB introduces scoring system for variant and clinical annotations and updated Levels of Evidence
›
Since their introduction in 2010, clinical annotations have become one of the most popular features of PharmGKB. Each clinical annotation s...
Tuesday, March 23, 2021
Two new pathways released: Allopurinol Pharmacokinetics and Pimozide Pharmacokinetics.
›
Allopurinol is a purine analogue used in the treatment of gout. This drug has a level A CPIC Guideline for allopurinol and HLA-B . The new p...
Monday, March 1, 2021
Milestones in Payer Coverage Set to Expand Pharmacogenomic Testing
›
A new perspective just out in Genetics in Medicine describes the improvements in the US payer landscape for pharmacogenomics test reim...
Friday, February 19, 2021
PharmGKB and CPIC curated information displayed on ClinGen
›
PharmGKB and CPIC partnered with ClinGen last summer to bring curated pharmacogenomics (PGx) to the resource which defines the clinical ...
Thursday, February 18, 2021
Plavix manufacturers to pay $834 million to state of Hawaii
›
Bristol-Myers Squibb Co and Sanofi, the manufacturers of Plavix (clopidogrel) have been ordered to pay over $834 million to the state of Haw...
Tuesday, February 16, 2021
HGVS annotations now available on PharmVar
›
We are excited to share that PharmVar is now providing HGVS annotations in addition to their more traditional annotations. To accommodate d...
Wednesday, February 10, 2021
Update to FDA-approved drug label annotations
›
In February 2020, we blogged about the FDA's newly released Table of Pharmacogenetic Associations . Since then, there has been much int...
‹
›
Home
View web version